Genzyme: Should investors push sale or refocus?

A sale of Genzyme might book a quick gain for its stockholders, but Reuters posits that a smaller, more focused Genzyme might be the better outcome for investors. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.